Request Demo
Last update 16 May 2025
CGT-1967
Last update 16 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms CGT 1967, CGT-1967, CGT1967 |
Target |
Action inhibitors |
Mechanism CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with CGT-1967CTR20250886
评价CGT-1967片治疗复发/难治性血液肿瘤患者的多中心、开放、剂量递增和剂量扩展的I期临床研究
[Translation] A multicenter, open-label, dose-escalation and dose-expansion phase I clinical study evaluating CGT-1967 tablets in the treatment of patients with relapsed/refractory hematological malignancies
100 Clinical Results associated with CGT-1967
Login to view more data
100 Translational Medicine associated with CGT-1967
Login to view more data
100 Patents (Medical) associated with CGT-1967
Login to view more data
100 Deals associated with CGT-1967
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Lymphoblastic Leukemia | Phase 1 | China | 07 Mar 2025 | |
| Acute Myeloid Leukemia | Phase 1 | China | 07 Mar 2025 | |
| Chronic Lymphocytic Leukemia | Phase 1 | China | 07 Mar 2025 | |
| Chronic Myelogenous Leukemia | Phase 1 | China | 07 Mar 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free